Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Dig Your Heels In: A Working Woman’s Series with YiDing Yu

YiDing Yu is the CMO at Olive, a practicing physician, published researcher, and serial entrepreneur. As a female in the healthcare and tech industries, she’s excited about the growth of women in healthcare. Yu said she grew up with a ton of interests. She knew she wanted to be a doctor when she was little….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Dig Your Heels In on MarketScale.

Share
Dig Your Heels In: A Working Woman’s Series with YiDing Yu

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

YiDing Yu is the CMO at Olive, a practicing physician, published researcher, and serial entrepreneur. As a female in the healthcare and tech industries, she’s excited about the growth of women in healthcare. Yu said she grew up with a ton of interests. She knew she wanted to be a doctor when she was little. But her love of politics and technology helped her combine her hobbies and develop beyond a practicing physician. Yu recalls she was driven by the thought of “how to solve the challenges I saw every day in healthcare” and eventually figured out that the “best way to solve that is working in systems.” And that’s how she got the tech bug.

According to an article published by the Harvard Business Review, for over 25 years, women have made up at least 40% of U.S. medical students, and in most recent years, more women than men have been enrolled in U.S. medical schools.

Yu lived this statistic, and she understands better than anyone that female enrollment in medical school is not reflective of women in leadership roles. Healthcare IT News found that despite the growth in women’s medical students, “only 25-30% percent of healthcare executives – and just 13% of CEOs – are female.” Yu has broken through that ceiling and has some empowering advice for how rising physicians can pave their way, and she reflects on what she learned from her development and male mentors.

Yu understands firsthand the struggle that women experience in the medical field. One of the first and most tangible things that she recommends is for aspiring healthcare leaders to protect their time for professional development. Women in medicine tend to put their patients first and professional development second. Yu recalls that her professional development occurred when she challenged herself and participated in special projects from administration to innovation. Once that starts, typically, development projects beget more development projects.

Be assertive and advocate for yourself. Chase that promotion, carve out time for professional development the way men are encouraged to, and source mentors who can strengthen your understanding of business strategy and financials. Always remember, you are the CEO of you. A recent study from Modern Healthcare News reported, “Typically, more men are exposed to finance and operations development than women, leading to lopsided leadership representation.”

Yu recalls learning to protect time to develop her leadership skills and forging her path by deviating from the style of male mentors. She says, “Every single role model who was in a position that I thought I might want was a man. Early in my career, I had to think through what is it like for a woman to be in that career? Do I have to act how they act?”

Yu urges women not to conform to the style of their male leaders if it isn’t natural for them. She recalls, “I felt like I was trying to dance a jig. Be enthusiastic but not too enthusiastic, assertive but not so assertive that you intimidate people.” Of course, professional behavior has to be upheld, but men and women operate differently. Successful leaders look different. They come in all different shapes, dialects, styles, and appearances.

Unfortunately, these trends will only continue until hospitals, corporations, and businesses around healthcare do not make a conscientious effort to drive a shift into more accurate representation.

In 2019 the US Census reported that a range of positions are dominated by women, but even where women outnumber men, like in nursing and speech pathology, they are not represented and excelling in leadership roles.

Of course, it takes time for generations to develop into leadership positions. Practitioners must challenge the status quo of academic structures and corporate structures to shift the fabric of the hierarchy and make it more inclusive.

To embrace diversity, companies have to start measuring it among their employees. Understanding the baseline and sharing it within creates conscious investment and accountability. Yu warns, “Without measurement, it’s easy to give yourself a pass.” At Olive, Yu has found that publishing that diversity measurement also acts as a gentle nudge for teams across the company.

In conclusion, Yu says it’s not just about the supply. It’s about how practitioners mentor and make leadership positions more accessible. She urges all professionals to understand that they have agency in this change. It may be as simple as reminding the acquisition team that you want to see more diversity.

For young professionals, know that agency lies in the ability to dedicate time to professional development. That likely means not picking up other physicians’ shifts to protect that growth. And finally, don’t be afraid to add flare into leadership. Many current leaders may not resemble females, but the female leadership style is bound to be just as successful.

Dig Your Heels In

Part of this channel

Dig Your Heels In

Business conversations for professionals who build on their own terms.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

Medicare's ACCESS pilot is live, but patients can't find which providers offer it

The Centers for Medicare & Medicaid Services (CMS) launched its tech-enabled chronic care pilot program, known as the ACCESS pilot. Despite its initiation, a significant issue persists as patients struggle to find which healthcare providers are participating in the program. Meanwhile, the FDA has authorized 115 AI-based medical devices in 2021.

  • 01CMS has initiated the ACCESS pilot program to enhance chronic care management using technology.
  • 02Patients are facing challenges in identifying healthcare providers involved in the ACCESS pilot.
  • 03In 2021, the FDA authorized 115 AI-based medical devices.

Aug 17, 2026

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

Sobi CEO Guido Oelkers named BioNTech's next chief executive, targeting multiple approved products by 2030

BioNTech has appointed Guido Oelkers, the current CEO of Sobi, as its next chief executive. Oelkers is tasked with advancing BioNTech's oncology pipeline to achieve multiple approved products by 2030.

  • 01BioNTech has selected Guido Oelkers as its new CEO, effective soon.
  • 02Guido Oelkers aims to turn BioNTech's deep oncology pipeline into several approved products by 2030.

Aug 17, 2026

Health systems are spending big on EHRs and AI while governance gaps widen

Health systems are spending big on EHRs and AI while governance gaps widen

Health systems are investing heavily in electronic health records (EHRs) and artificial intelligence (AI). However, there are notable governance gaps in AI implementation in hospitals. Many hospitals lack dedicated platforms for AI testing and reimbursement issues for AI remain unresolved.

  • 01Health systems are making significant financial investments in electronic health records and AI technology.
  • 02AI reimbursement policies remain unclear, posing challenges for healthcare providers.
  • 03Most hospitals do not have dedicated platforms for testing AI applications.

Aug 17, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512